Published in J Virol on February 01, 1997
Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev (1997) 6.88
P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol (2000) 5.64
Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo. J Virol (2004) 1.64
Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol (1997) 1.32
FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles. Mol Biol Cell (2002) 1.14
Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA (1998) 1.13
Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment. Mol Cell Biol (1997) 1.02
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell (1985) 11.28
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (1988) 10.15
Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell (1990) 8.11
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell (1989) 6.11
Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem (1994) 4.70
The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc Natl Acad Sci U S A (1991) 4.66
Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev (1989) 4.63
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A (1983) 4.56
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J (1989) 4.24
The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell (1988) 4.22
HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J (1991) 4.18
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. J Virol (1988) 3.69
An amino-terminal fragment of GAL4 binds DNA as a dimer. J Mol Biol (1989) 3.65
HIV-1 Tat protein trans-activates transcription in vitro. Cell (1990) 3.57
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell (1990) 3.36
The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev (1991) 3.08
HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev (1992) 2.85
Formation of the 3' end of U1 snRNA is directed by a conserved sequence located downstream of the coding region. EMBO J (1985) 2.69
Transcriptional antitermination. Nature (1993) 2.52
Does HIV-1 Tat induce a change in viral initiation rights? Cell (1993) 2.30
Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev (1990) 2.30
The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev (1992) 2.24
Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A (1991) 2.17
The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev (1990) 2.14
Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J (1995) 2.14
Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci U S A (1994) 2.14
HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. J Mol Biol (1993) 2.12
Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science (1990) 1.93
Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc Natl Acad Sci U S A (1990) 1.81
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J (1994) 1.78
Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res (1989) 1.70
Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein. J Virol (1990) 1.68
HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology (1994) 1.63
Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol Cell Biol (1993) 1.59
Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1990) 1.52
Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function. Proc Natl Acad Sci U S A (1992) 1.41
Multiple regions of TBP participate in the response to transcriptional activators in vivo. Genes Dev (1994) 1.33
Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J Virol (1992) 1.25
Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins. J Virol (1990) 1.25
Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs. Biochimie (1994) 1.24
RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator. Proc Natl Acad Sci U S A (1990) 1.09
Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. New Biol (1991) 1.07
Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. J Mol Biol (1993) 1.04
Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. J Biomed Sci (1995) 1.00
Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology (1995) 0.95
Delineating minimal protein domains and promoter elements for transcriptional activation by lentivirus Tat proteins. J Virol (1995) 0.86
Formation of a small ribonucleoprotein particle between Tat protein and trans-acting response element in human immunodeficiency virus-infected cells. J Biol Chem (1991) 0.85
Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly. J Virol (1996) 0.84
Inhibition of the dsRNA-dependent protein kinase by a peptide derived from the human immunodeficiency virus type 1 Tat protein. J Interferon Res (1993) 0.82
Splicing of in vitro synthesized messenger RNA precursors in HeLa cell extracts. Cell (1983) 5.82
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Formation of the 3' end of U1 snRNA requires compatible snRNA promoter elements. Cell (1986) 3.69
A 7 bp mutation converts a human RNA polymerase II snRNA promoter into an RNA polymerase III promoter. Cell (1989) 3.28
Formation of the 3' end of U1 snRNA is directed by a conserved sequence located downstream of the coding region. EMBO J (1985) 2.69
Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Genes Dev (1988) 2.38
A TBP complex essential for transcription from TATA-less but not TATA-containing RNA polymerase III promoters is part of the TFIIIB fraction. Cell (1992) 2.32
Targeting TBP to a non-TATA box cis-regulatory element: a TBP-containing complex activates transcription from snRNA promoters through the PSE. Genes Dev (1993) 2.27
A TBP-TAF complex required for transcription of human snRNA genes by RNA polymerase II and III. Nature (1995) 2.20
The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev (1990) 2.14
The cloned RNA polymerase II transcription factor IID selects RNA polymerase III to transcribe the human U6 gene in vitro. Genes Dev (1991) 1.85
Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters. Genes Dev (2000) 1.61
Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol Cell Biol (1993) 1.59
The large subunit of basal transcription factor SNAPc is a Myb domain protein that interacts with Oct-1. Mol Cell Biol (1998) 1.50
cis-acting elements required for RNA polymerase II and III transcription in the human U2 and U6 snRNA promoters. Nucleic Acids Res (1990) 1.43
The SNAP45 subunit of the small nuclear RNA (snRNA) activating protein complex is required for RNA polymerase II and III snRNA gene transcription and interacts with the TATA box binding protein. Proc Natl Acad Sci U S A (1996) 1.41
Cloning and characterization of SNAP50, a subunit of the snRNA-activating protein complex SNAPc. EMBO J (1996) 1.40
RNA polymerase III transcription from the human U6 and adenovirus type 2 VAI promoters has different requirements for human BRF, a subunit of human TFIIIB. Mol Cell Biol (1996) 1.39
Role for the amino-terminal region of human TBP in U6 snRNA transcription. Science (1997) 1.36
Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol (1997) 1.32
SNAP19 mediates the assembly of a functional core promoter complex (SNAPc) shared by RNA polymerases II and III. Genes Dev (1998) 1.31
The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc. Mol Cell Biol (1996) 1.26
Reconstitution of transcription from the human U6 small nuclear RNA promoter with eight recombinant polypeptides and a partially purified RNA polymerase III complex. J Biol Chem (2001) 1.22
SNAP(c): a core promoter factor with a built-in DNA-binding damper that is deactivated by the Oct-1 POU domain. Genes Dev (1999) 1.19
The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter. Mol Cell Biol (1999) 1.18
Monoclonal antibodies directed against the amino-terminal domain of human TBP cross-react with TBP from other species. Hybridoma (1996) 1.18
A positioned nucleosome on the human U6 promoter allows recruitment of SNAPc by the Oct-1 POU domain. Mol Cell (2001) 1.17
The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1. Genes Dev (1998) 1.11
FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res (1999) 1.10
Characterization of a trimeric complex containing Oct-1, SNAPc, and DNA. J Biol Chem (1997) 1.09
A map of protein-protein contacts within the small nuclear RNA-activating protein complex SNAPc. J Biol Chem (2000) 1.06
Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab (2006) 1.00
Crossing the line between RNA polymerases: transcription of human snRNA genes by RNA polymerases II and III. Cold Spring Harb Symp Quant Biol (1998) 1.00
The largest subunit of human RNA polymerase III is closely related to the largest subunit of yeast and trypanosome RNA polymerase III. Genome Res (1997) 0.92
Factors influencing the efficiency of T-DNA transfer during co-cultivation of Antirrhinum majus with Agrobacterium tumefaciens. Plant Cell Rep (1992) 0.90
Nanopore detection of single molecule RNAP-DNA transcription complex. Nano Lett (2012) 0.90
Relationships of sexual, physical, and emotional abuse to emotional and behavioral problems among incarcerated adolescents. J Child Sex Abus (2001) 0.87
Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly. J Virol (1996) 0.84
The isolation and companion comfort responses of 7- and 3-day-old rat pups are modulated by drugs active at the opioid receptor. Behav Neurosci (1996) 0.82
Correcting chordee without hypospadias and with deficient ventral skin: a new technique. BJU Int (2001) 0.80
The HIV-1 inducer of short transcripts activates the synthesis of 5,6-dichloro-1-beta-D-benzimidazole-resistant short transcripts in vitro. J Biol Chem (1998) 0.80
Predictability of electron cone ratios with respect to linac make and model. J Appl Clin Med Phys (2003) 0.79
Prevalence and correlates of rest tremor in essential tremor: cross-sectional survey of 831 patients across four distinct cohorts. Eur J Neurol (2015) 0.79
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate. Clin Infect Dis (1995) 0.78
Discrimination between biological motion with and without social intention: a pilot study using visual scanning in healthy adults. Int J Psychophysiol (2013) 0.78
Isolation alters striatal met-enkephalin immunoreactivity in rat pups. Physiol Behav (1996) 0.78
Variations in prudent laypersons' perceptions of the need for emergent medical care. J Emerg Med (2000) 0.77
The microtubule associated protein tau H1 haplotype and risk of essential tremor. Eur J Neurol (2013) 0.77
Evaluation of in vivo models for studying calcification behavior of commercially available bovine pericardium. J Heart Valve Dis (1998) 0.77
[Pancreatic cystic fibrosis in Mexicans over 15 years of age]. Rev Invest Clin (1991) 0.75
GM1 ganglioside reduces glutamate toxicity to cortical cells. Lowered LDH release and preserved membrane integrity. Mol Chem Neuropathol (1993) 0.75
Prevention of infectious complications of percutaneous nephrolithotomy. Minerva Urol Nefrol (2015) 0.75